Corvus Pharmaceuticals, Inc. · HAM:C17
Corvus Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 170 institutions reported holding Corvus Pharmaceuticals, Inc., 81.5% of its shares. Largest: Orbimed Advisors LLC, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Corvus Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Orbimed Advisors LLC | 7.17M | 8.5% | no change | Nov 16, 2026 |
| BlackRock | 7.1M | 8.4% | −38,415 | Nov 13, 2026 |
| Vanguard | 4.73M | 5.6% | −1,794 | Nov 13, 2026 |
| State Street | 3.33M | 3.9% | −1.14M | Nov 12, 2026 |
| Hood River Capital Management LLC | 3.31M | 3.9% | +1.74M | Nov 16, 2026 |
| Adams Street Partners LLC | 3.28M | 3.9% | no change | Nov 16, 2026 |
| T. Rowe Price | 3.06M | 3.6% | −731K | Nov 16, 2026 |
| Wellington | 2.85M | 3.4% | +120K | Nov 16, 2026 |
| Vivo Capital, LLC | 2.81M | 3.3% | no change | Nov 13, 2026 |
| Perceptive Advisors LLC | 2.51M | 3.0% | −157K | Nov 16, 2026 |